Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Biology and Environment (81)
- Advanced Manufacturing (22)
- Building Technologies (1)
- Clean Energy (85)
- Climate and Environmental Systems (1)
- Computational Biology (2)
- Fusion and Fission (4)
- Fusion Energy (1)
- Materials (25)
- Materials for Computing (5)
- National Security (7)
- Neutron Science (12)
- Nuclear Science and Technology (4)
- Supercomputing (15)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (11)
- (-) Biology (73)
- Advanced Reactors (1)
- Artificial Intelligence (9)
- Big Data (10)
- Bioenergy (45)
- Biomedical (16)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (11)
- Clean Water (11)
- Climate Change (41)
- Composites (5)
- Computer Science (19)
- Coronavirus (13)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (19)
- Energy Storage (7)
- Environment (90)
- Exascale Computing (4)
- Frontier (3)
- Fusion (1)
- Grid (3)
- High-Performance Computing (20)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (9)
- Materials (12)
- Materials Science (6)
- Mathematics (4)
- Mercury (7)
- Microscopy (10)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (3)
- Net Zero (2)
- Neutron Science (4)
- Nuclear Energy (1)
- Partnerships (5)
- Physics (2)
- Polymers (2)
- Renewable Energy (1)
- Security (2)
- Simulation (15)
- Summit (10)
- Sustainable Energy (30)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
Working backwards has moved Josh Michener’s research far forward as he uses evolution and genetics to engineer microbes for better conversion of plants into biofuels and biochemicals. In his work for the BioEnergy Science Center at ORNL, for instance, “we’ve gotten good at engineering microbes th...